On the relevance of prognostic information for clinical trials: A theoretical quantification
From MaRDI portal
Publication:6149266
DOI10.1002/bimj.202100349arXiv2111.03391WikidataQ126306350 ScholiaQ126306350MaRDI QIDQ6149266
Stephen Senn, Unnamed Author, Torsten Hothorn
Publication date: 4 March 2024
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2111.03391
Cites Work
- The prognostic analogue of the propensity score
- Boosting algorithms: regularization, prediction and model fitting
- Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control
- A Biometrics Invited Paper with Discussion. Some Aspects of Analysis of Covariance
- Some Surprising Results about Covariate Adjustment in Logistic Regression Models
- Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets
- Unnamed Item
This page was built for publication: On the relevance of prognostic information for clinical trials: A theoretical quantification